Skip to main content

Table 2 Laboratory data after 13 courses of hepatic arterial infusion chemotherapy

From: Advanced hepatocellular carcinoma with hepatic vein tumor thrombosis and renal dysfunction after hepatic arterial infusion chemotherapy effectively treated by liver resection with active veno-venous bypass: report of a case

Complete blood count    Tumor markers
WBC 5,100/μL ChE 307 IU/L AFP 13 ng/mL
RBC 323 ×104/μL LDH 191 IU/L PIVKA-II 15 mAU/mL
Hb 10.3 g/dL T-Chol 245 mg/dL   
Hct 30.5 % TP 7.0 g/dL Dye clearance test
Plt 14.6 ×104/μL Alb 4.5 g/dL ICG-R 15 9.7 %
   Na 140 mEq/L   
Coagulation tests K 5.4 mEq/L CT volumetry
PT-INR 1.11 Cl 106 mEq/L Whole liver 1082 ml
APTT 28.0 sec Ca 9.8 mg/dL Right lobe 297 ml (27.4 %)
Blood chemistry UA 8.6 mg/dL Left lobe 785 ml (72.6 %)
AST 19 IU/L UN 34.9 mg/dL   
ALT 14 IU/L Cr 1.93 mg/dL   
ALP 231 IU/L CRP 0.28 mg/dL   
γGTP 21 IU/L HbA1c 5.8 %   
T.Bil 0.6 mg/dL eGFR 27.1 mL/min/1.73 m2   
  1. AFP alpha-fetoprotein, Alb albumin, ALT alanine aminotransferase, ALP alkaline phosphatase, APTT activated partial thromboplastin time, AST aspartate aminotransferase, ChE cholinesterase, CRP C-reactive protein, eGFR estimated glomerular filtration rate, γGTP gamma glutamyl transpeptidase, HBV hepatitis B virus, Hb hemoglobin, HbA1c hemoglobin A1c, Hct hematocrit, HCV hepatitis C virus, ICG-R 15 indocyanine green dye retention rate at 15 min, LDH lactate dehydrogenase, Plt platelets, PT-INR prothrombin time-international normalized ratio, RBC red blood cells, T.Bil total bilirubin, T.Chol total cholesterol, PIVKA-II protein induced by vitamin K absence or antagonist, TP total protein, UA uric acid, UN urea nitrogen, WBC white blood cells